Top Markets
Coin of the day
Microba Life Sciences Limited Microba Life Sciences Limited

Microba Life Sciences Limited

MAP
주식 순위 #28053
Microba Life Sciences Limited, established in Brisbane, Australia, in 2017,... Microba Life Sciences Limited, established in Brisbane, Australia, in 2017, specializes in providing sophisticated microbiome testing and analytical services. These offerings reach clinicians, individual consumers, and research customers across key international markets, including Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, and the United States. The company delivers pathology, therapeutic, and diagnostic solutions deeply rooted in human gut microbiome science. Central to its operations is a comprehensive Databank, invaluable for unearthing therapeutic leads, fostering consumer health advancements, and identifying crucial diagnostic biomarkers. Moreover, Microba leverages a data-driven therapeutics platform to engineer innovative monoclonal microbial cell therapies aimed at treating inflammatory bowel disease, enhancing cancer immunotherapy, and managing autoimmune disorders.
주가
$0.04020123
시가총액
$28.83M
변동 (1일)
0.00%
변동 (1년)
-31.34%
국가
AU
거래 Microba Life Sciences Limited (MAP)

카테고리

Microba Life Sciences Limited (MAP)의 P/S 비율
2026 기준 P/S 비율 TTM: 0
Microba Life Sciences Limited의 최신 재무 보고서와 주가에 따르면 현재 P/S 비율(TTM)은 0입니다. 2026년 말 기준 P/S 비율은 0였습니다.
Microba Life Sciences Limited의 P/S 비율 기록 (2026 ~ 2026)
매년 말 P/S 비율
연도 P/S 비율 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 P/S 비율
회사 P/S 비율 P/S 비율 차이 국가
4.72 -
US
5.67 -
US
- -
CN
16.40 -
US
9.55 -
US